We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.
About Us
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and strive to deliver superior business results. Mercury Pharmaceuticals thrives to maintain an environment built on mutual respect and individual integrity. This includes our customers we serve, employees, shareholders, partners, suppliers and communities.
Mercury Pharmaceuticals manufacturing solutions include contract biomanufacturing services, bioprocess development and purification equipment.
We have unique manufacturing capabilities and a track record for viruses and viral vectors (lentivirus, AAV, ADV, etc.) for gene therapy and vaccination, and experience in manufacturing monoclonal antibodies including: conjugation, mAb fragments and other rec-proteins from fermentation and cell culture for a broad range of therapeutic indications. We can also provide you with purification process development, along with preparative and industrial purification equipment for biologic and small biomolecule manufacturing including LPLC, continuous chromatography, and tailor-made TFF systems.
With history in traditional medicine, we have developed several drug products isolated from plant extracts.
Our Team
We are always thriving to maintain on our core values at Mercury Pharmaceuticals, we embrace the principles of good corporate governance, implemented through strong, independent and diverse membership on our team. We are consistently implementing the best governance practices, it is more important than ever that we continually earn our investor's confidence. We will do this by remaining a leader in corporate governance and providing clear, consistent and truthful communication about our performance.
> Meet the minds behind our innovations:
RANDALL JOHNSTON, PhD Chief Executive Officer at Mercury Pharmaceuticals
STEVE H. JORDAN, PhDChief Innovation Officer at Mercury Pharmaceuticals
MENDEL GREEN, (PhD, MSc, MPH)Senior Consultant/Researcher at Mercury Pharmaceuticals
Evelyn BecksChief Operating Officer at Mercury Pharmaceuticals
Paul Clarke, PhD
Chief Scientific Officer at Mercury Pharmaceuticals
Eleonora OrdunaPresident, Manufacturing Operations at Mercury Pharmaceuticals
Vihaan ReddyPresident, Oncology at Mercury Pharmaceuticals
Mik VelaChief Purchasing Officer at Mercury Pharmaceuticals
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care. - Learn more
Cancer
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported. - Learn more
Neuroscience
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency. - Learn more
September is National Sickle Cell Awareness Month, and a University of Cincinnati College of Medicine hematology researcher has received new grant funding to study one of the disease's painful, under-recognized complications: bone damage.
Urinary tract infections, or UTIs, are among the most common bacterial infections, caused mostly by the uropathogenic bacterium Escherichia coli. But even after antibiotic treatment, a large number of patients experience another UTI.
